New Patient Support Program in Type 2 Diabetes
NCT03752567 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2020-02-12
Summary
Non-profit observational study on the role of the community pharmacist and the "pharmacy of services" in the case management of the diabetic patient
Conditions
- Diabetes Mellitus, Type 2
Interventions
- OTHER
-
Follow up
like group descriptions
Sponsors & Collaborators
-
Federfarma Campania
collaborator OTHER -
Federfarma Salerno
collaborator OTHER -
Health Telematic Network
collaborator INDUSTRY -
Biochemical Systems International S.p.A.
collaborator INDUSTRY -
Next Sight srl
collaborator INDUSTRY -
Farmacia La Regina s.r.l.
lead OTHER
Principal Investigators
-
Raffaele La Regina, dr · Farmacia La Regina s.r.l.
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-11-01
- Primary Completion
- 2019-10-31
- Completion
- 2019-10-31
Countries
- Italy
Study Locations
More Related Trials
-
Effects of Rosiglitazone and Metformin on Metabolism in Type 2 Diabetes
NCT02526615 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Dapagliflozin in Normal Clinical Practice in T2D
NCT05418946 ·Status: UNKNOWN
-
A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes
NCT07032688 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Tolerability of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Treated With Metformin and Sulfonylurea
NCT00995787 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of SGLT2-i Effectivness and Safety in Elderly Type 2 Diabetes Patients
NCT05477017 ·Status: UNKNOWN
-
Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects
NCT01156779 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study Evaluating the Safety and Efficacy of Roflumilast in Type 2 Diabetic Patients With Diabetic Neuropathy
NCT05369793 ·Status: COMPLETED ·Phase: PHASE3
-
RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes
NCT00379769 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy
NCT00515632 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus
NCT00532506 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes Subjects
NCT06688123 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study to Assess the Effect of Food on Combination Dapagliflozin/Metformin Tablet in Healthy Volunteers
NCT01156246 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus
NCT00057317 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
NCT02628392 ·Status: COMPLETED ·Phase: NA
-
Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus
NCT00057304 ·Status: COMPLETED ·Phase: PHASE2
-
A Study In Patients With Type 2 Diabetes Mellitus
NCT00256867 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Type 2 Diabetes Mellitus by L-Arginine in Patients With Metabolic Syndrome
NCT00917449 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Dapagliflozin Taken Twice-daily
NCT01217892 ·Status: COMPLETED ·Phase: PHASE3
-
Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes
NCT00373178 ·Status: COMPLETED ·Phase: PHASE4
-
Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuropathy
NCT01504412 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes
NCT00857558 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea
NCT01392677 ·Status: COMPLETED ·Phase: PHASE3
-
Screening Epidemiological Program on Compensation Evaluation of Diabetes Mellitus Type 2 (DMT2) Patients on Oral Anti-diabetic (OAD) Monotherapy and Physicians Satisfaction of Their Usage
NCT01275794 ·Status: COMPLETED
-
Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes
NCT01272804 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus
NCT02737891 ·Status: COMPLETED ·Phase: PHASE2